STAT Expert Advantage
A Look at the Breast Cancer Landscape: An Expert’s Take on the Newly Approved Daiichi Sankyo Drug, ENHERTU, SGEN’s tucatinib, & the Role of IO therapy
A Look at the Breast Cancer Landscape: An Expert’s Take on the Newly Approved Daiichi Sankyo Drug, ENHERTU, SGEN’s tucatinib, & the Role of IO therapy
The agency simply doesn’t have enough resources to challenge but 1% of hospital mergers, so they continue to result in less competition and higher prices.
One goal of freeing med students from the burden of student debt is to enable them to go into primary care or work in underserved…
The FTC’s noncompete ban could force sweeping changes in the health care industry, but implementation of the rule will almost certainly be held up by…
The genetic data point to a single spillover event that probably occurred in late 2023, the analysis by scientists in the U.S. and Europe suggests.
Testing conducted by the FDA on pasteurized commercially purchased milk has found genetic evidence of the H5N1 bird flu virus, the agency confirmed Tuesday.
The NIH will raise the minimum salary for postdocs to $61,008, responding to calls from young life scientists to provide a living wage.
The Joint Commission and the National Committee for Quality Assurance will launch updated accreditation programs for telehealth providers.
Easily a decade can pass before someone with a complex chronic condition gets a proper diagnosis. New telehealth companies aim to shorten that time and…
Congress did nothing this spring to rein in how pharmacy benefit managers operate, and the PBM industry spent big to get that result, new disclosures…
A new study shows that cross-market hospital mergers drive up prices, adding to evidence that could aid the FTC in blocking the deals.